Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The Swedish government and GE Healthcare are opening Testa Center to boost the commercialization of new technologies and support manufacturing capabilities in the life sciences sector.
read more
SwiftScale Biologics has successfully manufactured a COVID-19 neutralizing antibody candidate at clinical scale.
read more
Torqur AG, a clinical-stage biotechnology company advancing treatments for oncology and dermatology, and Lonza, a contract development and manufacturing organizations\ (CDMOs), announced an agreement for the clinical supply of bimiralisib, an ...
read more
Ginkgo Bioworks and Swissaustral announced a new partnership to design strains of microorganisms that will produce industrial enzymes at scale.
read more
Swissfillon AG has announced a partnership with Früh Verpackungstechnik AG, packaging manufacturer and supplier of medical and pharmaceutical contract packaging solutions.
read more
Tuesday, October 29, 2024
Southwest Research Institute recently ground on a new 21,000-square-foot Clinical Supply Facility to support government and industry clients with integrated pharmaceutical and bioengineering research and development.
read more
Tuesday, October 08, 2019
SwRI has received new funding from the MTEC and the FDA to use a SwRI-developed bioreactor to propagate cells for personalized regenerative medicine applications.
read more
Sygnature Discovery has acquired of Alderley Oncology, a focused in vivo pharmacology service provider which undertakes in vivo services for biotechs, pharmaceutical companies and academics.
read more
Sygnature Discovery is supporting Professor Sachin Gupte, a pharmacologist at the New York Medical College, in his endeavors to find a drug treatment for the lung damage that can result from COVID-19 infection.
read more
Wednesday, August 02, 2023
Sygnature Discovery announced the acquisition of Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market...
read more
Sygnature Discovery has acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein production and related structure determination projects within Sygnature. ...
read more
Thursday, October 01, 2020
Sygnature Discovery has expanded its DMPK capabilities with the acquisition of XenoGesis.
read more
OpenEye Scientific and Sygnature Discovery announced the adoption of OpenEye's Orion platform to power Sygnature's computational efforts in molecular design drug discovery solutions.
read more
Sygnature Discovery has announced the appointment of Dr. Paul Overton as Senior VP of Business Development.
read more
Wednesday, January 15, 2020
Sygnature Discovery has further strengthened its DMPK (drug metabolism and pharmacokinetics) capabilities, with the addition of new senior scientists to the management team.
read more